Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
Giredestrant 用于雌激素受体阳性、HER2 阴性、既往接受过治疗的晚期乳腺癌:来自随机、II 期 acelERA 乳腺癌研究的结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01500
Martín, Miguel; Lim, Elgene; Chavez-MacGregor, Mariana; Bardia, Aditya; Wu, Jiong; Zhang, Qingyuan; Nowecki, Zbigniew; Cruz, Felipe Melo; Safin, Rustem; Kim, Sung-Bae; Schem, Christian; Montero, Alberto J; Khan, Sarah; Bandyopadhyay, Reeti; Moore, Heather M; Shivhare, Mahesh; Patre, Monika; Martinalbo, Jorge; Roncoroni, Laura; Pérez-Moreno, Pablo Diego; Sohn, Joohyuk